Business
Why the Neuren (ASX:NEU) share price is moving higher today
Neuren Pharmaceuticals Ltd (ASX: NEU) shares are trending higher in early afternoon trade. This comes after the biotech company announced it has successfully completed manufacturing a drug substance for its Phase 2 trials.
At the time of writing, the Neuren share price has jumped to an intraday high of $1.28, up 1.99% for the day so far.
What did Neuren announce?
The Neuren share price is edging higher as investors appear pleased with the company’s progress.
According to its release, Neuren’s second drug candidate, NNZ-2591, has been manufactured ahead of Phase 2 trials. The company is currently preparing to submit Investigational New Drug…
-
Noosa News22 hours agoMassive wind farm project in Queensland axed amid community backlash
-
General10 hours agoAnne-Marie Te Whiu on new book of poetry, Mettle, and why she dedicated it to her younger self
-
Noosa News23 hours agoSailor airlifted to hospital after boat runs ashore near Double Island Point, Sunshine Coast
-
General20 hours agoKAP leader says he was unaware man next to him at rally was wearing neo-Nazi insignia